Compartir
Translational Vascular Medicine: Pathogenesis, Diagnosis, and Treatment (en Inglés)
Abraham, David ; Handler, Clive ; Dashwood, Michael (Autor)
·
Springer
· Tapa Blanda
Translational Vascular Medicine: Pathogenesis, Diagnosis, and Treatment (en Inglés) - Abraham, David ; Handler, Clive ; Dashwood, Michael
S/ 751,32
S/ 1.502,63
Ahorras: S/ 751,32
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Estados Unidos
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Viernes 21 de Junio y el
Martes 02 de Julio.
Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.
Reseña del libro "Translational Vascular Medicine: Pathogenesis, Diagnosis, and Treatment (en Inglés)"
Translational medicine underpins vascular medicine. It is fundamental to understanding how we treat patients with vascular disease and more importantly, how to prevent it. It is the rationale for drug design and production. Vascular medicine and translational medicine will take over and become the main reason for referring patients to hospital. Therefore, hospital-based clinicians working with basic scientists need to know about translational medicine, which educates and informs them about vascular medicine and how management should be based. Newly qualified and trained physicians are working in multidisciplinary groups of cardiologists, vascular surgeons, cardiac surgeons, lipidologists, diabetologists. Clinicians in the US, Australasia, the Far East and western Europe are interested in the molecular basis and treatments of vascular medicine and this encompasses translational medicine. This book is a primer for translational vascular medicine and discusses the evolving and exciting areas of basic science applied to vascular medicine. The book is based on the third vascular biology conference held at The Royal College of Physicians in 2008. It provides a large amount of new basic and clinical information and the contributors are world leaders.
